SCOLR Pharma, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906

Attached files

file	filename
10-Q - FORM 10-Q - SCOLR Pharma, Inc.	d10q.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - SCOLR Pharma, Inc.	dex311.htm
EX-10.1 - SECOND AMENDMENT TO LEASE - SCOLR Pharma, Inc.	dex101.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - SCOLR Pharma, Inc.	dex322.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - SCOLR Pharma, Inc.	dex312.htm
EX-10.2 - AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT - SCOLR Pharma, Inc.	dex102.htm
EX-10.3 - AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT - SCOLR Pharma, Inc.	dex103.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SCOLR Pharma, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen J. Turner, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


By:		/s/ STEPHEN J. TURNER
		Stephen J. Turner
		President and Chief Executive Officer
		SCOLR Pharma, Inc.

Date: May 9, 2011

Attached files

Stock widget

Investing forum

SCOLR Pharma, Inc. Reports